<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>K. Habashy | SONG LAB</title><link>https://playful-bavarois-78840e.netlify.app/author/k.-habashy/</link><atom:link href="https://playful-bavarois-78840e.netlify.app/author/k.-habashy/index.xml" rel="self" type="application/rss+xml"/><description>K. Habashy</description><generator>Hugo Blox Builder (https://hugoblox.com)</generator><language>en-us</language><lastBuildDate>Thu, 01 Jan 2026 00:00:00 +0000</lastBuildDate><image><url>https://playful-bavarois-78840e.netlify.app/media/logo_hu11652092127514912302.png</url><title>K. Habashy</title><link>https://playful-bavarois-78840e.netlify.app/author/k.-habashy/</link></image><item><title>YBX1&amp;YBX3 as novel targets to potentiate immune checkpoint blockade response in gliomas</title><link>https://playful-bavarois-78840e.netlify.app/publication/ybx1-ybx3-immune-checkpoint-glioma/</link><pubDate>Thu, 01 Jan 2026 00:00:00 +0000</pubDate><guid>https://playful-bavarois-78840e.netlify.app/publication/ybx1-ybx3-immune-checkpoint-glioma/</guid><description/></item></channel></rss>